Table 2. Evaluation of participants' IBD disease activity.

	Participants with Ulcerative Colitis(n=56)	Participants with Crohn's Disease(n=46)	P-value*
Index, Median (IQR) (range)	6-point Mayo,1(0-3)(0-6)	HBI, 2 (1-4) (0-12)
Disease activity stage			0.301
Remission phase, n (%)	38 (67.86%)	37 (80.43%)
Mild active phase, n (%)	4 (7.14%)	4 (8.70%)
Moderate active phase, n (%)	13 (23.21%)	5 (10.87%)
Severe active phase, n (%)	1 (1.79%)	0 (0%)

HBI: Harvey-Bradshaw Index.

*Chi-square test was used to test whether there was a statistically significant difference in the proportion of the disease activity between UC and CD patients.